WCO-IOF 2016: Alfacalcidol (Vit D analogue) vs. cholecalciferol (Vit D) for osteoporosis
The effect of alfacalcidol and plain vitamin D on osteoporosis: a randomized controlled trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
80 patients with osteoporosis were randomized to receive either alfacalcidol, a vitamin D analogue, or plain vitamin D (cholecalciferol). Both treatment groups also received calcium supplementation and alendronate. The purpose of this study was to compare the effects on bone mineral density and T-score between alfacalcidol and cholecalciferol. Results demonstrated no significant differences betwee...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE